Comment on ‘Robot pill’ technology reaches clinical trial stage

‘Robot pill’ technology reaches clinical trial stage

A cutting-edge development from Endiatx, a pioneering medical technology company, is aiming to bring a ‘robot pill’ to the market. Since its formation in 2019, the company has been striving to achieve its ambition of creating tiny robots to be ingested into the human body for diagnostic and therapeutic purposes. It sounds like something from a sci-fi movie and possibly dystopian, but this project is far from a figment of imagination. Endiatx’s flagship product is the PillBot, a robotic capsule equipped with various parts including cameras, sensors, and wireless communication to enable doctors or practitioners to examine the gastrointestinal tract with diligence, uncharted precision, and control. In an interview with VentureBeat, the company CEO Torrey Smith detailed how they have raised $7 million over the course, with the largest contribution of $1.5m gained from Verge Health Tech Fund, based in Singapore.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News